Author:
Chen Bo,Liu Caigang,Lu Yang,Lu Ping,Jin Feng,Yao Fan,Zhang Ruishan,Liu Jinlong,Zhao Shicheng
Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Takebe N, Zhao SC, Ural AU, et al. Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34+-enriched peripheral blood progenitor cells. Cancer Gene Ther, 2001, 8: 966–973.
2. Belur LR, Boelk-Galvan D, Diers MD, et al. Methotrexate accumulates to similar levels in animals transplanted with normal versus drug-resistant transgenic marrow. Cancer Res, 2001, 61: 1522–1526.
3. Takebe N, Xu LC, MacKenzie KL, et al. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene. Cancer Gene Ther, 2002, 9: 308–320.
4. Capiaux GM, Budak-Alpdogan T, Takebe N, et al. Retroviral transduction of a mutant dihydrofolate reductase-thymidylate synthase fusion gene into murine marrow cells confers resistance to both methotrexate and 5-fluorouracil. Hum Gene Ther, 2003, 14: 435–446.
5. Eliopoulos N, Al-Khaldi A, Beausejour CM, et al. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells. Gene Ther, 2002, 9: 452–462.